Targeted News Service

Multiple Myeloma Research Foundation: Myeloma Investment Fund Invests in Reverb Therapeutics to Support Debut of Its Amplifier Platform for Redirecting Endogenous Cytokines
November 16, 2023

NORWALK, Connecticut, Nov. 16 -- The Multiple Myeloma Research Foundation issued the following news on Nov. 15, 2023:

The Myeloma Investment Fund (MIF), the Multiple Myeloma Research Foundation's (MMRF) venture philanthropy subsidiary, today announced an investment in Reverb Therapeutics to explore the potential of its antibody-based Amplifier(TM) platform for the treatment of multiple myeloma with endogenous cytokines that naturally occur within the body.

Reverb is a s . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form